Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs

BACKGROUND: Lymphedema is a common complication of cancer therapeutics; its prevalence, treatment outcomes, and costs have been poorly defined. The objective of this study was to examine lymphedema prevalence among cancer survivors and to characterize changes in clinical outcomes and costs associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Brayton, Kimberly M., Hirsch, Alan T., O′Brien, Patricia J., Cheville, Andrea, Karaca-Mandic, Pinar, Rockson, Stanley G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255037/
https://www.ncbi.nlm.nih.gov/pubmed/25470383
http://dx.doi.org/10.1371/journal.pone.0114597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255037/
https://www.ncbi.nlm.nih.gov/pubmed/25470383
http://dx.doi.org/10.1371/journal.pone.0114597

Ejemplares similares